OurCrowd announces its new $200 million Global Health Equity Fund
OurCrowd has announced the launch of its new $200 million global health equity fund. Learn more about the fund here!
OurCrowd’s new Health Equity Fund aims to help people living in developing countries access healthcare services.
OurCrowd‘s new Health Equity Fund will invest in companies that provide affordable healthcare solutions.
OurCrowd, a global crowdfunding company, announced today announced its new fund called Global Health Equity at the FundatClinton Global Initiative event today in New York. GHEF) has partnered with the WHO Foundation to launch a $200 million fund that will focus on health solutions that could have a global impact.
Before the pandemic, OurCrowd had been investing in medical startups for a long time, but it only accelerated during the pandemic and I can best say that he is the founder and CEO of the company. For John Medvedev, it has become a somewhat personal mission. “COVID-19 was a wake-up call for me as an investor,” Medvedev said. “The pandemic has opened my eyes to health inequalities around the world and empowered the potential of innovative technologies to save
lives […]
Cooperation with the WHO Foundation allows us the most exciting investments and for investors and entrepreneurs to have equal access to the technologies we support want Allow the promise to be simplified. While the background focus is on health, The management team here has a broader vision that goes beyond medical startups, including further
areas that are rather indirectly on health. It can have an impact, such as on energy and agriculture.
OurCrowd aligns its funding with the WHO Foundation‘s Access Commitment.
This is to ensure that the portfolio companies’ solutions, which are accessible to populations connected with inequality. Specifically, this means that each GHEF portfolio company will find an access plan for its solutions, and the WHO Foundation and OurCrowd will let them do the same. It will set up an advisory board that will support it. Finally is not something most startups are used to and not necessarily something most mutual funds want. focus on their business. Instead of health care seems correct.
Anil Soni, CEO of the WHO Foundation, said, “Despite having clear models for successfully balancing economic returns with equitable access to medicines for HIV and AIDS, The world has failed to reach the solution to COVID-19 to all, everywhere. “It is essential that we put in place solutions in response to those failures, including directing investments toward innovation and as a goal from the outset. Aligning with equity. ”
OurCrowd CEO Medved, OurCrowd Managing Partner Maurice Laster, and the firm’s team of clinical experts will lead the fund’s team, while WHO Foundation‘s Impact Investment Officer Geetha Thamararatnam will also be assisted.
